Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis
Supporting Files
Public Domain
-
10 2021
-
File Language:
English
Details
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:Prophylactic trimethoprim/sulfamethoxazole (TMP/SMX) prevents Pneumocystis jirovecii pneumonia and nocardiosis in immunocompromised patients but sometimes is avoided because of purported allergies or side effects. Of 25 immunocompromised patients receiving alternative prophylaxis in whom nocardiosis developed, 16 subsequently tolerated TMP/SMX treatment. Clinicians should consider TMP/SMX allergy evaluation and rechallenging to assess patient tolerance.
-
Subjects:
-
Source:Emerg Infect Dis. 27(10):2734-2736
-
Pubmed ID:34545802
-
Pubmed Central ID:PMC8462344
-
Document Type:
-
Volume:27
-
Issue:10
-
Collection(s):
-
Main Document Checksum:urn:sha256:f17b2809bfbb16a08767dde6241ce7b8818c3de0df4616a1f081a231c32b3e34
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Emerging Infectious Diseases